RIAPT
LIVE

Serial Number

79188746

Owner

NOVARTIS AG

Filing Date

Apr 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

RIAPT Trademark

Serial Number: 79188746 • Registration: 5070827

RIAPT is a trademark filed by NOVARTIS AG on April 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

April 1, 2016

Registration Date

November 1, 2016

Published for Opposition

August 16, 2016

Cancellation Date

August 7, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; anti-fungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Mar 9, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Mar 9, 2020 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Sep 29, 2017 INNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 9, 2017 OPNX
NOTIFICATION PROCESSED BY IB
Feb 10, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2016 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2016 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Dec 1, 2016 GPAR
REGISTERED-PRINCIPAL REGISTER
Nov 1, 2016 R.PR
PUBLISHED FOR OPPOSITION
Aug 16, 2016 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 10, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 10, 2016 OP2R
NOTICE OF PUBLICATION
Jul 27, 2016 NPUB
APPLICATION FILING RECEIPT MAILED
Jul 15, 2016 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2016 CNSA
ASSIGNED TO EXAMINER
Jul 11, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 11, 2016 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 8, 2016 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jul 7, 2016 SDRC